Low-dose naltrexone use for the management of post-acute sequelae of COVID-19.
Bonilla H, Tian L, Marconi VC, Shafer R, McComsey GA, Miglis M, Yang P, Bonilla A, Eggert L, Geng LN.
Bonilla H, et al. Among authors: bonilla a.
Int Immunopharmacol. 2023 Nov;124(Pt B):110966. doi: 10.1016/j.intimp.2023.110966. Epub 2023 Oct 5.
Int Immunopharmacol. 2023.
PMID: 37804660
Free PMC article.